Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was added and the previous Revision: v3.6.3 was removed, indicating a small update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-07-25T16:48:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.2 to v3.6.3. This appears to be a minor maintenance/version-control update rather than a substantive change to the study information or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-04T08:08:54.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a backend release update. No visible changes to study details or page content are evident.
    Difference
    0.0%
    Check dated 2026-06-27T03:25:37.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    - Added user guidance sections: How to Read a Study Record, Common Questions, How to Join a Study, and a recruitment status note: 'No longer looking for participants'. - Updated revision/version label to v3.6.0 and adjusted the Intervention/Treatment heading formatting (from 'Intervention / Treatment').
    Difference
    0.4%
    Check dated 2026-06-12T16:32:18.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.4 to v3.5.5, indicating a routine backend/display update rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T12:33:40.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    The study record now shows that results have been posted for OP-1250, replacing prior results-submission statuses, and includes detailed study design, eligibility criteria, cohorts, outcomes, and links to associated documents.
    Difference
    3%
    Check dated 2026-05-15T05:37:47.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.